BR112019022400A2 - cateter ureteral e sistema para induzir pressão negativa em uma porção do trato urinário de um paciente - Google Patents
cateter ureteral e sistema para induzir pressão negativa em uma porção do trato urinário de um paciente Download PDFInfo
- Publication number
- BR112019022400A2 BR112019022400A2 BR112019022400A BR112019022400A BR112019022400A2 BR 112019022400 A2 BR112019022400 A2 BR 112019022400A2 BR 112019022400 A BR112019022400 A BR 112019022400A BR 112019022400 A BR112019022400 A BR 112019022400A BR 112019022400 A2 BR112019022400 A2 BR 112019022400A2
- Authority
- BR
- Brazil
- Prior art keywords
- tube
- expandable
- distal end
- ureteral
- retaining portion
- Prior art date
Links
- 210000001635 urinary tract Anatomy 0.000 title claims description 37
- 210000003734 kidney Anatomy 0.000 claims abstract description 226
- 210000000244 kidney pelvis Anatomy 0.000 claims abstract description 132
- 239000012530 fluid Substances 0.000 claims abstract description 131
- 210000000626 ureter Anatomy 0.000 claims abstract description 124
- 230000014759 maintenance of location Effects 0.000 claims abstract description 71
- 230000007704 transition Effects 0.000 claims abstract description 12
- 210000002700 urine Anatomy 0.000 claims description 146
- 238000000034 method Methods 0.000 claims description 69
- 239000000463 material Substances 0.000 claims description 60
- 230000035699 permeability Effects 0.000 claims description 18
- 210000001519 tissue Anatomy 0.000 claims description 17
- 238000004891 communication Methods 0.000 claims description 14
- -1 polyethylene Polymers 0.000 claims description 9
- 230000004323 axial length Effects 0.000 claims description 8
- 230000002093 peripheral effect Effects 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 5
- 239000004800 polyvinyl chloride Substances 0.000 claims description 5
- 230000035945 sensitivity Effects 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 4
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 210000004400 mucous membrane Anatomy 0.000 claims description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 description 199
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 44
- 210000004369 blood Anatomy 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 238000005534 hematocrit Methods 0.000 description 25
- 210000005239 tubule Anatomy 0.000 description 25
- 229940109239 creatinine Drugs 0.000 description 22
- 210000003708 urethra Anatomy 0.000 description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 19
- 239000011734 sodium Substances 0.000 description 19
- 229910052708 sodium Inorganic materials 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 16
- 238000002560 therapeutic procedure Methods 0.000 description 16
- 208000009304 Acute Kidney Injury Diseases 0.000 description 14
- 208000033626 Renal failure acute Diseases 0.000 description 14
- 201000011040 acute kidney failure Diseases 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- 238000002637 fluid replacement therapy Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000012544 monitoring process Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 210000000885 nephron Anatomy 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 230000002485 urinary effect Effects 0.000 description 11
- 210000001631 vena cava inferior Anatomy 0.000 description 11
- 206010059484 Haemodilution Diseases 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 238000001356 surgical procedure Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 206010020565 Hyperaemia Diseases 0.000 description 9
- 230000002706 hydrostatic effect Effects 0.000 description 9
- 230000003907 kidney function Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000009724 venous congestion Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 7
- 210000002565 arteriole Anatomy 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000010412 perfusion Effects 0.000 description 7
- 230000009103 reabsorption Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 206010016803 Fluid overload Diseases 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 6
- 239000012491 analyte Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004276 hyalin Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 206010016807 Fluid retention Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000001736 capillary Anatomy 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 210000005084 renal tissue Anatomy 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- 230000009056 active transport Effects 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 230000000004 hemodynamic effect Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000004990 Cardiorenal syndrome Diseases 0.000 description 3
- 206010062237 Renal impairment Diseases 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102100038026 DNA fragmentation factor subunit alpha Human genes 0.000 description 2
- 101710182628 DNA fragmentation factor subunit alpha Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 206010041277 Sodium retention Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000002665 bowman capsule Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000018875 hypoxemia Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000005977 kidney dysfunction Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 210000000210 loop of henle Anatomy 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 210000000512 proximal kidney tubule Anatomy 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- ZHVLGOLHHYJSBZ-QRPNPIFTSA-N (2s)-1-phenylpropan-2-amine;phosphoric acid Chemical compound OP(O)(O)=O.C[C@H](N)CC1=CC=CC=C1 ZHVLGOLHHYJSBZ-QRPNPIFTSA-N 0.000 description 1
- 206010058808 Abdominal compartment syndrome Diseases 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- 241000282619 Hylobates lar Species 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 208000002623 Intra-Abdominal Hypertension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000013156 embolectomy Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 210000001282 glomerular podocyte Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 210000003246 kidney medulla Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000021023 sodium intake Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/008—Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/047—Urethrae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
- A61M1/732—Visual indicating means for vacuum pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/78—Means for preventing overflow or contamination of the pumping systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/87—Details of the aspiration tip, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1082—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489789P | 2017-04-25 | 2017-04-25 | |
| US201762489831P | 2017-04-25 | 2017-04-25 | |
| US15/687,064 US10765834B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US15/687,083 US10926062B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US201815745823A | 2018-01-18 | 2018-01-18 | |
| PCT/US2018/015282 WO2018200052A1 (en) | 2017-04-25 | 2018-01-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019022400A2 true BR112019022400A2 (pt) | 2020-05-19 |
Family
ID=63918653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019022400A BR112019022400A2 (pt) | 2017-04-25 | 2018-01-25 | cateter ureteral e sistema para induzir pressão negativa em uma porção do trato urinário de um paciente |
Country Status (6)
| Country | Link |
|---|---|
| EP (4) | EP3614963A4 (enExample) |
| JP (2) | JP7084942B2 (enExample) |
| CN (2) | CN110785201A (enExample) |
| BR (1) | BR112019022400A2 (enExample) |
| ES (1) | ES2912785T3 (enExample) |
| WO (3) | WO2018200050A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017015351A2 (en) | 2015-07-20 | 2017-01-26 | Strataca Systems, LLC | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
| US10918827B2 (en) | 2015-07-20 | 2021-02-16 | Strataca Systems Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
| US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US10512713B2 (en) | 2015-07-20 | 2019-12-24 | Strataca Systems Limited | Method of removing excess fluid from a patient with hemodilution |
| US10493232B2 (en) | 2015-07-20 | 2019-12-03 | Strataca Systems Limited | Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function |
| US11229771B2 (en) | 2015-07-20 | 2022-01-25 | Roivios Limited | Percutaneous ureteral catheter |
| US11040180B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Systems, kits and methods for inducing negative pressure to increase renal function |
| US12064567B2 (en) | 2015-07-20 | 2024-08-20 | Roivios Limited | Percutaneous urinary catheter |
| US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| AU2018320515B2 (en) | 2017-08-25 | 2023-08-17 | Roivios Limited | Indwelling pump for facilitating removal of urine from the urinary tract |
| EP3883630B1 (en) * | 2018-11-21 | 2023-09-27 | Coloplast A/S | An intermittent urinary catheter |
| CN113382756A (zh) * | 2018-11-30 | 2021-09-10 | 斯特拉塔卡系统有限公司 | 涂覆和/或浸渍输尿管导管或支架及其制造方法 |
| KR102880227B1 (ko) * | 2019-02-08 | 2025-11-03 | 컬러플라스트 에이/에스 | 도뇨관 |
| EP3718593B1 (en) * | 2019-04-02 | 2022-12-14 | Universität Regensburg - Universitätsklinikum | Transurethral catheter device for bleeding control in pelvic fractures |
| US11628271B2 (en) * | 2019-06-10 | 2023-04-18 | Spinal Singularity, Inc. | Urinary catheter |
| CN111249045B (zh) * | 2020-01-17 | 2021-09-21 | 浙江医高医疗科技有限公司 | 改良的输尿管支架系统及其置入方法 |
| US20210370019A1 (en) * | 2020-05-28 | 2021-12-02 | Strataca Systems Limited | Method of Treatment Using Negative Pressure Renal Therapy and Medicament(s) |
| GB2603124B (en) * | 2021-01-22 | 2024-08-14 | Cambridge Univ Hospitals Nhs Foundation Trust | Vacuum Therapy Devices and Methods |
| BR112023020871A2 (pt) * | 2021-04-09 | 2023-12-12 | Purewick Corp | Condutos incluindo pelo menos um conduto de material poroso |
| US12472301B2 (en) | 2021-08-13 | 2025-11-18 | 3Ive Labs, Llc | Negative pressure therapy system and methods |
| CN114404780A (zh) * | 2022-01-24 | 2022-04-29 | 成都维宁生物技术有限公司 | 无囊防漏留置导尿管及其制造方法和用途 |
| CN114558179A (zh) * | 2022-03-04 | 2022-05-31 | 成都莫瑞克生物技术有限公司 | 自开式瓣状导尿管及其制造方法和用途 |
| US20230364322A1 (en) * | 2022-05-10 | 2023-11-16 | Roivios Limited | Wearable Garment for Negative Pressure Therapy |
| CN117282001A (zh) * | 2022-06-17 | 2023-12-26 | 上海交通大学医学院附属仁济医院 | 一种用于泌尿科的多药物涂层抗肿瘤的输尿管支架 |
| WO2024062218A1 (en) * | 2022-09-20 | 2024-03-28 | Convatec Limited | A catheter |
| CN116370805A (zh) * | 2023-04-20 | 2023-07-04 | 山东威高集团医用高分子制品股份有限公司 | 一种输尿管支架及支架放置套装 |
| CN119701112B (zh) * | 2025-02-28 | 2025-06-06 | 复旦大学 | 一种淋巴引流装置 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3397699A (en) * | 1966-05-05 | 1968-08-20 | Gerald C. Kohl | Retaining catheter having resiliently biased wing flanges |
| US5562622A (en) * | 1995-03-20 | 1996-10-08 | Contimed, Inc. | Self-cleansing bladder drainage device |
| US6500158B1 (en) * | 1997-03-26 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Method of inducing negative pressure in the urinary collecting system and apparatus therefor |
| US6332892B1 (en) * | 1999-03-02 | 2001-12-25 | Scimed Life Systems, Inc. | Medical device with one or more helical coils |
| US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
| US6558350B1 (en) * | 2000-06-20 | 2003-05-06 | Applied Medical Resources Corp. | Drainage catheter |
| EP1341482B2 (en) * | 2000-12-11 | 2016-05-18 | OrbusNeich Medical, Inc. | Stent having helical elements |
| US8506647B2 (en) * | 2002-02-14 | 2013-08-13 | Boston Scientific Scimed, Inc. | System for maintaining body canal patency |
| CN2588940Y (zh) * | 2002-10-31 | 2003-12-03 | 上海富士能高内镜有限公司 | 一种扩张吸引器 |
| WO2006044621A2 (en) * | 2004-10-15 | 2006-04-27 | The Regents Of The University Of California | Improved drainage system |
| US7931630B2 (en) * | 2005-07-05 | 2011-04-26 | C. R. Bard, Inc. | Multi-functional and modular urine collection system |
| EP1942971B1 (en) * | 2005-08-31 | 2011-06-29 | Cook Medical Technologies LLC | Catheter for implantation of Stents |
| MY162248A (en) | 2005-12-09 | 2017-05-31 | Dsm Ip Assets Bv | Hydrophilic coating |
| US20080255550A1 (en) * | 2006-11-30 | 2008-10-16 | Minos Medical | Systems and methods for less invasive neutralization by ablation of tissue including the appendix and gall bladder |
| US20090105719A1 (en) * | 2007-10-19 | 2009-04-23 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Precision stent positioner |
| CN100548245C (zh) * | 2007-12-21 | 2009-10-14 | 山东大学 | 微创负压膀胱穿刺造瘘留置装置及其工作方法 |
| US9788928B2 (en) * | 2008-10-10 | 2017-10-17 | Peter Forsell | Implantable device for internal urinary control |
| HUE033632T2 (en) * | 2009-01-18 | 2017-12-28 | Ocon Medical Ltd | Novel intra uterine device |
| EP4282363A3 (en) * | 2011-01-19 | 2024-01-10 | Fractyl Health, Inc. | Devices for the treatment of tissue |
| BR112013030183A2 (pt) * | 2011-05-23 | 2017-12-05 | Lazarus Effect Inc | dispositivo médico intervencional para recuperar e assegurrar uma obstrução dentro de um lúmen de vaso, método de assegurar uma obstrução dentro de um vaso, método de preparação de um dispositivo de recuperação, sistema de recuperação de dispositivo médico, para assegurar uma obstrução dentro de um lúmen de vaso e para uso com um cateter configurado para ser navegado através da vasculatura, dispositivo médico intervencional para assegurar um dispositivo de recuperação tendo uma ou mais obstruções localizadas nele para remoção de um corpo e dispositivo de recuperação do stent para se expandir contra um ou mais corpos oclusivos em uma vasculatura |
| US9132040B2 (en) * | 2011-11-17 | 2015-09-15 | Ethicon, Inc. | Dressing device |
| EP2749309B1 (en) * | 2012-12-28 | 2016-04-27 | Cook Medical Technologies LLC | Ion exchange ureteral stent |
| WO2015157467A1 (en) * | 2014-04-10 | 2015-10-15 | C.R. Bard, Inc. | Ureteral stents |
| EP3160400A4 (en) * | 2014-06-27 | 2018-06-27 | UroGen Pharma Ltd. | A connectable catheter |
| CN204246651U (zh) * | 2014-11-17 | 2015-04-08 | 江苏省人民医院 | 一种易于置换的输尿管支架管 |
| CN205126495U (zh) * | 2015-07-14 | 2016-04-06 | 王洛 | 多分支管肠道套接组件 |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| WO2017015351A2 (en) | 2015-07-20 | 2017-01-26 | Strataca Systems, LLC | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| MX2018000824A (es) * | 2015-07-20 | 2018-05-04 | Dispositivo de sonda y metodo para inducir presion negativa en la vejiga de un paciente. | |
| WO2017019974A1 (en) | 2015-07-29 | 2017-02-02 | Renastent Llc | Transformable ureteral stent |
| CN106237417A (zh) * | 2016-05-19 | 2016-12-21 | 黄健 | 一种多功能灌注吸引平台及使用方法 |
| CN106473847A (zh) * | 2016-11-22 | 2017-03-08 | 曹庆杰 | 可降解的膨胀性局部尿路腔内支架系统 |
| EP4005479B1 (en) * | 2017-01-20 | 2024-11-06 | Roivios Limited | System for removing excess fluid from a patient with hemodilution |
-
2018
- 2018-01-25 JP JP2019557576A patent/JP7084942B2/ja active Active
- 2018-01-25 EP EP18790948.6A patent/EP3614963A4/en active Pending
- 2018-01-25 CN CN201880042008.0A patent/CN110785201A/zh active Pending
- 2018-01-25 CN CN201880027590.3A patent/CN110636816A/zh active Pending
- 2018-01-25 EP EP18791301.7A patent/EP3615125A4/en not_active Withdrawn
- 2018-01-25 WO PCT/US2018/015260 patent/WO2018200050A1/en not_active Ceased
- 2018-01-25 ES ES18791406T patent/ES2912785T3/es active Active
- 2018-01-25 EP EP22152135.4A patent/EP4008372A1/en not_active Withdrawn
- 2018-01-25 EP EP18791406.4A patent/EP3600146B1/en active Active
- 2018-01-25 BR BR112019022400A patent/BR112019022400A2/pt not_active Application Discontinuation
- 2018-01-25 WO PCT/US2018/015282 patent/WO2018200052A1/en not_active Ceased
- 2018-01-25 JP JP2019557555A patent/JP2020517359A/ja active Pending
- 2018-01-25 WO PCT/US2018/015271 patent/WO2018200051A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3600146A4 (en) | 2020-04-15 |
| CN110636816A (zh) | 2019-12-31 |
| EP3600146B1 (en) | 2022-03-02 |
| WO2018200051A8 (en) | 2018-12-27 |
| ES2912785T3 (es) | 2022-05-27 |
| EP3600146A1 (en) | 2020-02-05 |
| JP2020517361A (ja) | 2020-06-18 |
| JP7084942B2 (ja) | 2022-06-15 |
| WO2018200050A1 (en) | 2018-11-01 |
| EP3615125A4 (en) | 2021-01-20 |
| JP2020517359A (ja) | 2020-06-18 |
| EP4008372A1 (en) | 2022-06-08 |
| WO2018200052A1 (en) | 2018-11-01 |
| CN110785201A (zh) | 2020-02-11 |
| EP3614963A1 (en) | 2020-03-04 |
| EP3615125A1 (en) | 2020-03-04 |
| EP3614963A4 (en) | 2021-01-13 |
| WO2018200051A1 (en) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019022400A2 (pt) | cateter ureteral e sistema para induzir pressão negativa em uma porção do trato urinário de um paciente | |
| US20220265914A1 (en) | Negative Pressure Therapy System | |
| US20210138190A1 (en) | Negative Pressure Therapy System | |
| US10765834B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| ES2911641T3 (es) | Sistema para remover el exceso de fluido de un paciente con hemodilución | |
| US20200054800A1 (en) | Catheter and Method for Inducing Negative Pressure in a Patient's Bladder | |
| US11918754B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| EP3672656A1 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| WO2018200643A1 (en) | Catheter and method for inducing negative pressure in a patient's bladder | |
| BR112020003829A2 (pt) | método para facilitar a saída de urina a partir do rim, cateter ureteral e sistema para induzir pressão negativa em uma porção do trato urinário de um paciente | |
| BR112021010025A2 (pt) | cateter, sistema para induzir pressão negativa em uma porção de um trato urinário de um paciente e método para remover fluido de um trato urinário de um paciente | |
| US11752300B2 (en) | Catheter device and method for inducing negative pressure in a patient's bladder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ROIVIOS LIMITED (BS) |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |